Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: A case study

摘要: Background: Psychotherapies for psychosis typically aim to develop an awareness of the implausible content a delusion or target underlying cognitive biases (i.e., problematic thinking styles, such as hasty decisions and illusory control) that foster maintain delusional beliefs. A recently designed individual-based treatment entitled metacognitive therapy (MCT+) combines these two approaches. Emerging evidence suggests individualised MCT+, when used concurrently with antipsychotic medication, may be effective psychological reducing symptoms. However, it remains tested whether MCT+ can in patients active delusions who are not currently receiving psychotropic drugs. Method: We present cases (one patient schizophrenia other disorder) experiencing underwent four-weeks intensive without concurrent medication (minimum 6-months unmedicated). Baseline 6-week follow-up data presented on variety measures assessing symptom severity PANSS, PSYRATS, SAPS), clinical insight, bias propensity. Results: After 4-weeks both showed substantial reduction symptoms, reported improved were less prone making correlations. Conclusions: The case studies provide preliminary feasibility treating taking, resistant to, medication.